A new insight into cell signals that control cancer growth and migration could help in the search for effective anti-cancer drugs. A McGill-led study reveals key biochemical processes that advance our understanding of colorectal cancer, the third most common cancer among Canadians.
Category:
Published on: 12 Aug 2020
Study identifies rapidly dividing cancer stem cells that can respond to new therapies
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Category:
Published on: 8 Jul 2020
An international team, that includes researchers from McGill, has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment.
Category:
Published on: 5 Feb 2020
Category:
Published on: 29 Apr 2019
McGill University has helped develop a global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1/BRCA2 data.
Category:
Published on: 9 Jan 2019
How does cancer spread? While studying human brain tumour cells, a team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) found some answers to this crucial, yet so far unanswered question. They looked at a gene called EGFRvIII, which is present in patients with glioblastoma – a highly aggressive form of brain cancer that spreads quickly and that is difficult to treat.
Category:
Published on: 10 Dec 2018
A team from The Research Institute of the MUHC and researchers at the Johns Hopkins Institute in the U.S. have developed a test they say is safe and could save lives.
CTV News, Montreal Gazette
Category:
Published on: 22 Mar 2018
At this early stage, the potential for harm is real while the benefits are only surrogate measures, said Kimmelman, an associate professor of biomedical ethics at McGill University. One such measure at Phase 1 might be tumor shrinkage, which does not necessarily translate into what people really care about: survival.
Stat News
Category:
Published on: 21 Feb 2018
Category:
Published on: 31 Aug 2017
Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from McGill University suggests.
Category:
Published on: 29 Jun 2017
Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cells
Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers.
Category:
Published on: 28 Jun 2017
Does the biological clock in cancer cells influence tumour growth? Yes, according to a study conducted by Nicolas Cermakian, a professor in McGill University’s Department of Psychiatry.
Published in the journal BMC Biology, these results show for the first time that directly targeting the biological clock in a cancerous tumour has an impact on its development.
Category:
Published on: 16 Feb 2017
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of 15% of adult cancers of the throat linked to alcohol and tobacco use. This is a first in the field of epigenetics and the researchers are hopeful that the discovery can blaze a path in the development of new, targeted, more effective treatments that could arise over the next few years.
Category:
Published on: 11 Jan 2017
Just four weeks of prehabilitation (pre-surgery preparation) may be enough to help some cancer patients get in shape for surgery. That’s according to a recent study of close to 120 colorectal cancer patients in Montreal. This potentially means that, barring unforeseen circumstances that stem from the surgery itself, their recovery is likely to be speedier too, according to earlier research from the same McGill-led team.
Category:
Published on: 1 Dec 2016
Pages
